Abstract

Computer aided toxicity and pharmacokinetic prediction studies attracted the attention of pharmaceutical industries as an alternative means to predict potential drug candidates. In the present study, in-silico pharmacokinetic properties (ADME), drug-likeness, toxicity profiles of sixteen antidiabetic flavonoids that have ideal bidentate chelating sites for metal ion coordination were examined using SwissADME, Pro Tox II, vNN and ADMETlab web tools. Density functional theory (DFT) calculations were also employed to calculate quantum chemical descriptors of the compounds. Molecular docking studies against human alpha amylase were also conducted. The results were compared with the control drugs, metformin and acarbose. The drug-likeness prediction results showed that all flavonoids, except myricetin, were found to obey Lipinski’s rule of five for their drug like molecular nature. Pharmacokinetically, chrysin, wogonin, genistein, baicalein, and apigenin showed best absorption profile with human intestinal absorption (HIA) value of ≥ 30%, compared to the other flavonoids. Baicalein, butein, ellagic acid, eriodyctiol, Fisetin and quercetin were predicted to show carcinogenicity. The flavonoid derivatives considered in this study are predicted to be suitable molecules for CYP3A probes, except eriodyctiol which interacts with P-glycoprotein (p-gp). The toxicological endpoints prediction analysis showed that the median lethal dose (LD50) values range from 159–3919 mg/Kg, of which baicalein and quercetin are found to be mutagenic whereas butein is found to be the only immunotoxin. Molecular docking studies showed that the significant interaction (-7.5 to -8.3 kcal/mol) of the studied molecules in the binding pocket of the α-amylase protein relative to the control metformin with the crucial amino acids Asp 197, Glu 233, Asp 197, Glu 233, Trp 59, Tyr 62, His 101, Leu 162, Arg 195, His 299 and Leu 165. Chrysin was predicted to be a ligand with high absorption and lipophilicity with 84.6% absorption compared to metformin (78.3%). Moreover, quantum chemical, ADMET, drug-likeness and molecular docking profiles predicted that chrysin is a good bidentate ligand.

Highlights

  • Computational pharmacology is a fast-growing research field focusing on the development of techniques for employing software and databases to generate and analyze molecular, biological and medical data from diverse sources [1, 2]

  • LogP and number of hydrogen bond acceptors (NHBAs) of all flavonoids are within the recognized values of less than 500, 3 and 10, respectively

  • On contrary to previous report on ellagic acid (5) studied using pkCSM server [6], our study showed positive result predicted by ADMETlab for ellagic acid (5) to permeate Blood Brain Barrier (BBB)

Read more

Summary

Introduction

Computational pharmacology is a fast-growing research field focusing on the development of techniques for employing software and databases to generate and analyze molecular, biological and medical data from diverse sources [1, 2]. Due to limited pharmacokinetics and toxicity profile of new drug-like molecules, only 11% of the drugs succeed to enter clinical development stage to reach the market [4, 8]. The pharmaceutical industries remain under immense pressure to counter the high rate of attrition in drug development that triggered an increase in the interest of computer aided toxicity and pharmacokinetic profile predictions [9]. There has been marvelous advancement in the area of computer aided drug design and computational chemistry. These methods have been used for screening of new chemical species and their chemical properties [12]. Web-based platforms—ADMETlab, Pro Tox-II and SwissADME—have been developed to predict ADMET properties [3, 4, 13]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.